Chanakya Nath Kundu
Overview
Explore the profile of Chanakya Nath Kundu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
84
Citations
977
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Das C, Kundu C
Crit Rev Microbiol
. 2025 Mar;
:1-24.
PMID: 40051042
Infections account for approximately 15% of human cancers worldwide. Viruses are the most predominant infectious agents and can infect and alter various types of human cells thereby leading to the...
2.
Das S, Nayak A, Siddharth S, Nayak D, Narayan S, Kundu C
Cell Oncol (Dordr)
. 2025 Feb;
PMID: 39962014
No abstract available.
3.
Pradhan A, Biswal S, Bhal S, Biswal B, Kundu C, Subuddhi U, et al.
ACS Appl Bio Mater
. 2025 Feb;
8(2):1418-1436.
PMID: 39907519
A biodegradable and biocompatible micellar-based drug delivery system was developed using amphiphilic methoxy-poly(ethylene glycol)-cholesterol ( and poly(ethylene glycol)-S-S-cholesterol () conjugates and applied to the tumoral release of the water-insoluble drug...
4.
Arega S, Dey S, Pani S, Dash S, Budhwar R, Kundu C, et al.
Genomics
. 2024 Nov;
116(6):110957.
PMID: 39510199
This study investigates the role of the long non-coding RNA Maternally Expressed Gene3 (lncRNA MEG3) gene in cervical cancer, as evidenced by its downregulation in cancerous cell lines. The study...
5.
Saini M, Paul S, Acharya A, Acharya S, Kundu C, Guchhait S
Bioorg Chem
. 2024 Aug;
152:107738.
PMID: 39182257
Almost half of all medicines approved by the U.S. Food and Drug Administration have been found to be developed based on inspiration from natural products (NPs). Here, we report a...
6.
Thakur C, Martins F, Karthikeyan C, Bhal S, Kundu C, Moorthy N, et al.
J Mol Model
. 2024 Jul;
30(8):261.
PMID: 38985223
Context: Multiwalled carbon nanotubes (MWCNTs) functionalized with lysine via 1,3-dipolar cycloaddition and conjugated to galactose or mannose are potential nanocarriers that can effectively bind to the lectin receptor in MDA-MB-231...
7.
Bhal S, Das B, Sinha S, Das C, Acharya S, Maji J, et al.
Med Oncol
. 2024 Jun;
41(7):167.
PMID: 38831079
Cancer stem cells (CSCs) are mainly responsible for tumorigenesis, chemoresistance, and cancer recurrence. CSCs growth and progression are regulated by multiple signaling cascades including Wnt/β-catenin and Hh/GLI-1, which acts independently...
8.
Acharya S, Kundu C
Cancer Treat Rev
. 2024 May;
127:102749.
PMID: 38714074
Cancer cells merely exist in isolation; rather, they exist in an intricate microenvironment composed of blood vessels, signalling molecules, immune cells, stroma, fibroblasts, and the ECM. The TME provides a...
9.
Das B, Kundu C
Methods Mol Biol
. 2024 Mar;
2777:219-230.
PMID: 38478347
Cancer stem cells (CSCs) exhibit intricate regulatory dynamics within the tumor microenvironment, involving interactions with various components like mesenchymal stem cells (MSCs), adipocytes, cancer-associated fibroblasts (CAFs), endothelial cells, tumor-associated macrophages...
10.
Pradhan R, Kundu A, Kundu C
Crit Rev Oncol Hematol
. 2024 Mar;
196:104311.
PMID: 38442808
It is a well-known fact that cancer can be augmented by infections and inflammation. In fact, chronic inflammation establishes a tumor-supporting-microenvironment (TME), which contributes to neoplastic progression. Presently, extensive research...